ROBOX · Project

Enzyme-Based Chemical Manufacturing That Cuts Costs and Emissions by Half

manufacturingPilotedTRL 6

h2020robox.eu

Most chemicals we use every day — from plastics to pharmaceuticals — need oxygen added to them during production, and that step usually requires harsh chemicals, high temperatures, and lots of energy. ROBOX figured out how to use specially engineered enzymes (biological catalysts, like the ones in your laundry detergent) to do the same job at room temperature using just air. Think of it as replacing a blowtorch with a precision tool. The team tested 11 different industrial reactions at large scale across pharmaceuticals, nutrition, specialty chemicals, and materials — proving these enzyme processes can work outside the lab.

By the numbers

up to 50%

Cost reduction vs. conventional chemical oxidation

60%

Energy use reduction

50%

GHG emissions reduction

16%

Chemical usage reduction

Target reactions demonstrated at large scale

6,000+ ktons/year

Combined addressable market volume

>€1,000/kg

Current pharma end-product price point where enzymes are already used

The business problem

What needed solving

Chemical manufacturers rely on energy-intensive, high-temperature oxidation processes that consume expensive chemicals and generate significant emissions. Biocatalytic alternatives using enzymes have existed but were only economically viable in pharma, where end-product prices exceed €1,000/kg. Lower-margin industries like specialty chemicals, nutrition, and materials could not justify the cost of enzyme-based processes — until now.

The solution

What was built

The project delivered four families of robust oxidative enzymes (P450s, BVMOs, ADH, AOX) with optimized production strains and bioreactor processes including downstream processing. It also produced high-throughput screening platforms (96-well capillary electrophoresis, flow cytometry, quorum sensing microfluidics) and validated 11 target reactions at large scale across pharma, nutrition, specialty chemicals, and materials sectors.

Audience

Who needs this

Specialty chemical manufacturers running expensive oxidation processesPharmaceutical API producers and contract manufacturing organizationsFood ingredient and nutrition companies seeking greener production methodsBio-based materials companies replacing petrochemical processesIndustrial biotechnology companies looking for licensed enzyme platforms

Business applications

Who can put this to work

Specialty & Fine Chemicals

mid-size

Target: Chemical manufacturers producing alcohols, ketones, or oxidized intermediates

If you are a specialty chemical producer dealing with expensive, energy-intensive oxidation steps — ROBOX developed robust oxidative enzymes (P450s, BVMOs, ADH, AOX) that demonstrated up to 50% cost reduction and 60% energy savings at large scale. The project validated 11 target reactions ready for scale-up to commercial plants, targeting markets with a combined volume of over 6,000 ktons/year.

Pharmaceutical Manufacturing

enterprise

Target: API manufacturers and contract manufacturing organizations (CMOs)

If you are a pharma manufacturer spending heavily on chemical oxidation steps for active pharmaceutical ingredients — ROBOX delivered improved P450 enzyme variants for hydroxylation of APIs, along with optimized enzyme production processes in bioreactors. The project built screening systems and production strains specifically designed to make biocatalytic oxidation viable beyond the current high-price pharma segment (>€1,000/kg products).

Bio-based Materials & Nutrition

any

Target: Companies producing food ingredients, flavors, or bio-based materials

If you are a nutrition or materials company looking to replace chemical oxidation with greener processes — ROBOX demonstrated enzymatic bio-oxidation routes that operate at ambient temperature and pressure using just air as the oxygen source. The project targets a 50% reduction in GHG emissions and 16% reduction in chemical usage, with validated large-scale demonstrations across nutrition and materials applications.

Frequently asked

Quick answers

How much could this actually save us compared to conventional chemical oxidation?

Based on the project objectives, ROBOX targets up to 50% cost reduction, 60% lower energy use, 16% fewer chemicals consumed, and 50% reduction in greenhouse gas emissions. These figures apply to the shift from traditional chemical oxidation to enzymatic bio-oxidation at industrial scale.

Has this been tested at industrial scale or only in the lab?

ROBOX demonstrated 11 target reactions at large scale, specifically to prepare them for scale-up to commercial-scale plants. The project also delivered optimized enzyme production processes in bioreactors including downstream processing (DSP), moving well beyond lab-scale validation.

What about IP and licensing — can we actually use these enzymes?

The consortium includes 2 major industrial players and 9 SMEs across 10 countries, with a 48% industry ratio. Licensing and IP arrangements would need to be negotiated with the consortium partners, particularly the coordinator Rijksuniversiteit Groningen. SciTransfer can facilitate introductions to the right contact.

Which specific enzyme types were developed and for what reactions?

Four types of robust oxidative enzymes were validated: P450 monooxygenases for hydroxylation of aromatics, alkenes, and APIs; Baeyer-Villiger Monooxygenases (BVMOs) for ketone oxidation; Alcohol Dehydrogenase (ADH) and Alcohol Oxidase (AOX) for alcohol conversions. The deliverables include first generation production strains and improved enzyme variants.

How mature are the screening and production tools?

The project delivered multiple screening platforms: a 96-well capillary electrophoresis system, flow cytometer-based screening with fluorogenic sensors, quorum sensing technology, and a microfluidics platform. These are described as platform technologies designed for broad replication across the chemical industry.

What markets does this address and how big are they?

The markets addressed within ROBOX represent a combined volume of over 6,000 ktons per year, spanning pharmaceuticals, nutrition, fine and specialty chemicals, and materials. The project specifically aims to expand biocatalysis beyond the pharma segment into larger-volume, lower-price chemical markets.

What is the timeline to adopt this in our production?

The project ended in March 2019 and delivered optimized enzyme production processes including downstream processing. Integration timeline depends on your specific reaction and scale requirements. The consortium developed plug-and-play expression systems designed to accelerate adoption, but commercial deployment would require a technology transfer discussion with the partners.

Consortium

Who built it

The ROBOX consortium is exceptionally strong for commercial follow-through: 25 partners across 10 European countries with a 48% industry ratio — nearly half the consortium are companies, not universities. With 12 industrial partners including 2 major players and 9 SMEs, this project was explicitly industry-driven. The coordinator is Rijksuniversiteit Groningen in the Netherlands, a leading biocatalysis research center. The geographic spread (AT, BE, CH, CZ, DE, DK, ES, IT, NL, UK) covers major European chemical manufacturing hubs. For a business looking to adopt this technology, this consortium means established industry relationships and multiple potential technology providers already familiar with the results.

RIJKSUNIVERSITEIT GRONINGENCoordinator · NL
DSM MATERIALS SCIENCE CENTER BVthirdparty · NL
INNOSYN BVparticipant · NL
TECHNISCHE UNIVERSITAET GRAZparticipant · AT
THE UNIVERSITY OF MANCHESTERparticipant · UK
DSM FOOD SPECIALTIES BVthirdparty · NL
ACIB GMBHparticipant · AT
GENENCOR INTERNATIONAL BVparticipant · NL
RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHENparticipant · DE
CHEMSTREAM BVBAparticipant · BE
C-LECTA GMBHparticipant · DE
PNO CONSULTANTS BVparticipant · NL
UNIVERSITEIT MAASTRICHTparticipant · NL
GIVAUDAN SUISSE SAparticipant · CH
UNIVERSITA DEGLI STUDI DI PAVIAparticipant · IT
EVOXX TECHNOLOGIES GMBHparticipant · DE
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICHparticipant · CH
DANMARKS TEKNISKE UNIVERSITETparticipant · DK
UNIVERSITAT AUTONOMA DE BARCELONAparticipant · ES
PNO INNOVATIONthirdparty · BE
DYADIC NEDERLAND BVparticipant · NL

How to reach the team

Rijksuniversiteit Groningen (Netherlands) — contact through SciTransfer for a warm introduction to the right team member.

Order a report on this consortium See RIJKSUNIVERSITEIT GRONINGEN profile →

Next steps

Talk to the team behind this work.

Want to explore how ROBOX enzyme technology could cut your oxidation costs by up to 50%? SciTransfer can connect you directly with the consortium partners best suited to your specific process. Contact us for a free one-page technology brief.

Order a report on this topic More in Manufacturing & Industry 4.0